Could the decline in #prostatecancer diagnoses usher in an increase in death rates? #cancer screening

There are a lot of problems with cancer screening. Explaining and understanding the calculus behind the tests is not easy.  Suffice to say that early detection is generally not the life saver we thought it would be. Now comes a steep decline in prostate cancer diagnoses. Harvard's Meir Stampfer asks where that's good news or bad … Continue reading Could the decline in #prostatecancer diagnoses usher in an increase in death rates? #cancer screening

Advertisements

Overdiagnosis or overtreatment? Move to lung cancer screening fuels debate

A report from HLM on Siemens-sponsored, Atlantic-hosted event on "The Diagnostic Debate." Gregory Sorensen, the CEO of Siemens Healthcare North America opened the session by challenging the notion that screening drives overdiagnosis. "We're not over diagnosing," he said. "We're over treating." Sorensen used as an example, mammography. When doctors find a "low-grade" tumor like DCIS … Continue reading Overdiagnosis or overtreatment? Move to lung cancer screening fuels debate

Globe on reform and the cost of screening

See KHN and the usual suspects for the news on the possible demise of the public insurance plan option in the reform package.   The Globe offers a story this morning about the cost-saving potential of preventive health and screening.  While cholesterol tests, cancer screenings, and other preventive measures can save lives, there is strong disagreement about … Continue reading Globe on reform and the cost of screening